Companies / Belgium
Solvay Records Promising Results
February 2007 | Company Finance AlertBelgium industrial conglomerate Solvay recorded strong results in 2006, driven by surging sales for its pharmaceuticals division. Turnover in 2006 reached EUR9.4bn (US$12.3bn), with pharmaceuticals accounting for 28% of this total after growing 15% in 2006 to EUR2.6bn (US$3.4bn).
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
